Vaxxinity, Inc. (VAXX) Social Stream



Vaxxinity, Inc. (VAXX): $0.72

0.03 (+4.14%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add VAXX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#292 of 365

in industry

VAXXINITY INC (VAXX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering VAXXINITY INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 2 $21 $21 $21 $0.77 2627.27%
2021-12-29 2 $21 $18 $19.5 $0.77 2432.47%
2022-03-24 2 $18 $17 $17.5 $0.77 2172.73%
2022-03-25 2 $18 $14 $16 $0.77 1977.92%
2022-05-10 3 $18 $14 $16 $0.77 1977.92%
2022-11-11 3 $18 $12 $15 $0.77 1848.05%
2023-03-27 3 $15 $12 $13.5 $0.77 1653.25%
2023-03-31 3 $15 $10 $12.5 $0.77 1523.38%
2023-08-11 3 $15 $10 $12.5 $0.77 1523.38%
2023-09-08 3 $15 $7 $10.666 $0.77 1285.19%
NA 1 $NA $NA $NA $0.77 NA%

The Trend in the Analyst Price Target


VAXX's average price target has moved down $5.33 over the prior 16 months.

VAXX reports an average of 466.47% for its upside potential over the past 32 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-27 3 15 12 13.5 2.16 525%
2023-03-31 2 15 10 12.5 2.27 450.66%
2023-03-31 3 15 10 12.5 2.27 450.66%
2023-08-11 2 15 10 12.5 2.38 425.21%
2023-09-08 2 15 7 11.0 1.71 543.27%

VAXX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


VAXX's average broker recommendation rating improved by 0.67 over the prior 39 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • VAXXINITY INC's number of analysts covering the stock is higher than 61.26% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, VAXXINITY INC's upside potential (average analyst target price relative to current price) is greater than 1181.81% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VAXXINITY INC's variance in analysts' estimates is lower than -175.26% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, VAXXINITY INC's average analyst price target is higher than 311.04% of them.

Stocks similar to VAXXINITY INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GNLX, PASG, and BDTX.

Is VAXX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!